Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production

Journal of Interferon and Cytokine Research

Volumn 16, Issue 7, 1996, Pages 555-559

  Fujisawa, Hiroshi ^a   Shivji, Gulnar M ^a   Kondo, Seiji ^a   Wang, Binghe ^a   Tomai, Mark A ^b   Miller, Richard L ^b   Sauder, Daniel N ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DRUG ANALOG; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOMODULATING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; RESIQUIMOD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0029844041     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.555     Document Type: Article

References (27)

1. MILLER, R.L., IMBERTSON, L.M., REITER, M.J., SCHWARZMILLER, PECORE, S.E., and GERSTER, J.F. (1985). Inhibition of herpes simplex virus infection in guinea pig model by S-26308. Abstracts of ASM, Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Minneapolis, MN, p. 235 (Abstract).
2. BERNSTEIN, D.I., and HARRISON, C.J. (1991). Effects of the immunomodulating agent R-836 on acute and latent herpes simplex virus type 2 infections. Antimicrob. Agents Chemother. 33, 1511-1515.
3. HARRISON, C.J., JENSKI, L., VOYCHEHOVSKI, T., and BERNSTEIN, D.I. (1988). Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection. Antiviral Res. 10, 209-224.
4. HARRISON, C.J., STANBERRY, L.R., and BERNSTEIN, D.I. (1991). Effects of cytokine and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs. Antiviral Res. 15, 315-322.
5. SIDKY, Y.A., BORDEN, E.C., WEEKS, C.E., REITER, M.J., HATCHER, J.F., and BRYAN, G.T. (1992). Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res. 52, 3528-3533.
6. MILLER, R.L., IMBERTSON, L.M., REITER, M.J., PECORE, S.E., and GERSTER, J.F. (1986). Interferon induction by antiviral S-26308 in guinea pigs. Abstracts of ASM, Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, p. 168.
7. WITT, P.L., RTTCH, P.S., REDING, D., McAULIFFE, T.L., WESTRICK, L., GROSSBERG, S.E., and BORDEN, E.C. (1993). Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. Cancer Res. 53, 5176-5180.
8. WEEKS, C.E., and GIBSON, S.J. (1993). Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J. Interferon Res. 14, 93-97.
9. REITER, M.J., TESTERMAN, T.L., MILLER, R.L., WEEKS, C.E., and TOMAI, M.A. (1994). Cytokine induction in mice by the immunomodulator imiquimod, J. Leukocyte Biol. 55, 234-240.
10. TESTERMAN, T.L., IMBERTSON, L.M., REITER, M.J., MILLER, R.L., WAGNER, T.L., and TOMAI, M.A. (1995). Cytokine induction by the immunomodulators imiquimod and S-27609. J. Leukocyte Biol. 58, 365-372.
11. GIBSON, S.J., IMBERTSON, L.M., WAGNER, T.L., TESTERMAN, T.L., REITER, M.J., MILLER, R.L., and TOMAI, M.A. (1995). Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J. Interferon Cytokine Res. 15, 537-545.
12. KONO, T., KONDO, S., PASTORE, S., SHIVJI, G.M., TOMAI, M.A., McKENZIE, R.C., and SAUDER, D.N. (1994). Effect of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res. 13, 71-76.
13. TOMAI, M.A., GIBSON, S.J., IMBERTSON, L.M., MILLER, R.L., MYHRE, P.E., REITER, M.J., WAGNER, T.L., TAMULINAS, C.B., BEAURLINE, J.M., GERSTER, J.F., and HORTON, V.L. (1995). Immunomodulating and antiviral activities of the imidazoquinoline S-28463. Antiviral Res. 28, 253-264.
14. KONDO, S., KONO, T., SAUDER, D.N., and McKENZIE, R.C. (1993). Il-8 gene expression and production in human keratinocytes and their modulation by UVB. J. Invest. Dermatol. 10, 690-694.
15. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
16. DUSTIN, M.L., ROTHLEIN, R., BHAN, A.K., DINARELLO, C.A., and SPRINGER, T.A. (1986). Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adhesion molecule-1 (ICAM-1). J. Immunol. 137, 245-254.
17. VAN DAMME, J., and OPDENAKKER G. (1990). Interaction of interferons with skin reactive cytokines: from interleukin-1 to interleukin-8. J. Invest. Dermatol. 95, 90s-93s.
18. ARIBIA, M.B., LEROY, E., LANTZ, O., METIVIER, D., AUTRAN, B., CHARPENTIER, B., HERCEND, T., and SENIK, A. (1987). IL-2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL-1 and IL-2. J. Immunol. 139, 443-451.
19. LARSEN, C.G., ANDERSON, A.O., APPELLA, E., OPPENHEIM, J.J., and MATSUSHIMA, K. (1989). Neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243, 1464-1466.
20. COLDITZ, I., ZWAHLEN, R., DEWALD, B., and BAGGIOLINI, M. (1989). In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocyte. Am. J. Pathol. 134, 755-760.
21. HAN, J., BROWN, T., and BEUTLER, B. (1990). Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475.
22. CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N., and WILLIAMSON, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
23. HEIDENREICH, S., WEYERS, M., GONG, J.H., SPRENGER, H., NAIN, M., and GEMSA, D. (1988). Potentiation of lymphokine induced macrophage activation by tumor necrosis factor-α. J. Immunol. 140, 1511-1518.
24. MUNKER, R., GASSON, J., OGAWA, M., and KOEFFLER, H.P. (1986). Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323, 79-82.
25. DINARELLO, C.A., CANNON, J.G., WOLFF, S.M., BERNHEIM, H.A., BEUTLER, B., CERAMI, A., FIGARI, I.S., PALLADINO, M.A., and O'CONNOR, J.V. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163, 1433-1450.
26. BARKER, J.N.W.N., SARMA, V., MITRA, R.S., and NIKOLOFF, B.J. (1989). Marked synergism between tumor necrosis factor-α and interferon-γ in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J. Clin. Invest. 85, 605-608.
27. 2, and is inhibited by specific antibodies to IFN-β. J. Immunol. 140, 1566-1570.